This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University System of Maryland, Regenerative Research Foundation. Active years: 2012-2025.
Company Filing History:
2 out of 2,025 
1 out of 9 Years Active: 2012-2025
Title: Innovations by Steven Lance Bernstein
Introduction
Steven Lance Bernstein is an accomplished inventor based in Chevy Chase, MD (US). He holds two patents that focus on groundbreaking methods for treating optic nerve diseases. His work has significant implications for conditions such as glaucoma, showcasing his commitment to advancing medical science.
Latest Patents
Bernstein's latest patents include innovative methods of treating optic nerve diseases using neural progenitor cell growth factors. His first patent details the use of optic nerve lamina region neural progenitor cells (ONLR-NPCs), which secrete growth and survival factors beneficial for treating optic nerve diseases. The second patent provides a method for reducing damage to the optic nerve by administering prostaglandin J2, either alone or in combination with GM-CSF, particularly in mammals, including humans.
Career Highlights
Throughout his career, Bernstein has worked with notable organizations, including the University System of Maryland and the Regenerative Research Foundation. His contributions to the field of regenerative medicine have been recognized for their potential to improve patient outcomes in ophthalmology.
Collaborations
Bernstein has collaborated with esteemed colleagues such as Candace L. Kerr and Sally Temple Stern. These partnerships have further enriched his research and development efforts in the field of optic nerve treatment.
Conclusion
Steven Lance Bernstein's innovative work in treating optic nerve diseases highlights his significant contributions to medical science. His patents reflect a dedication to improving therapies for conditions like glaucoma, ultimately benefiting patients and advancing the field.